# Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab

> **NCT07749001** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Western University, Canada** · enrollment: 36 (estimated)

## Conditions studied

- COPD (Chronic Obstructive Pulmonary Disease)

## Interventions

- **DRUG:** Mepolizumab 100 MG Injection

## Key facts

- **NCT ID:** NCT07749001
- **Lead sponsor:** Western University, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-02-28
- **Final completion:** 2028-04-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749001, "Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*